Former Zantac Users Have Few Options Left Other Than Adopting a Healthy Lifestyle

Zantac cancer victims continue to file lawsuits as alternative heartburn medicines may be just as dangerous

Friday, July 10, 2020 - Heartburn and acid reflux medication Zantac and others have been recalled under the suspicion that the antacid tablets contain above the daily intake level of N-Nitrosodimethylamine (NDMA), a deadly carcinogen. The US Food and Drug Administration has set the level of acceptable NDMA at 96 nanograms (ng) per tablet but online drug testing pharmacy Valisure found levels thousands of times greater. Hundreds of former Zantac users have hired Zantac Cancer Lawyers to file claims alleging that ingesting Zantac regularly over several years led to their cancer. Stomach cancer, bladder, intestinal, prostate, breast, and esophageal cancer are just some of alleged cancer that has been caused by Zantac.

The most recent lawsuit was filed in United States District Court for the Southern District of Florida on June 17 by plaintiff Aaron Hayden. According to About Lawsuits, "the plaintiff regularly took Zantac from 2014 until the end of 2017, indicating that the exposure to NDMA from Zantac was the direct cause of his bladder cancer diagnosis." Lawsuits against Sanofi, the manufacturer of Zantac, claim that the company knew or should have known of the risks that carcinogenic levels of NDMA could develop and chose not to inform consumers, and instead pocketed billions of dollars in profits each year from sales of the world's best-selling antacid medicine.

Legal experts think that tens of thousands of cancer-sufferers will come forward in the next several months and hire a Zantac Cancer Lawyer to file a claim against Sanofi and others. In addition to Zantac heartburn and acid reflux medication, certain diabetes drugs called metformin has also been recalled for similar reasons, prompting Valisure CEO David Light to call the drug recalls only the tip of the iceberg. Light feels that consumer confidence could be shaken by the FDA's inability to monitor drug production overseas in countries like China. The FDA fears that so many types of medications could have elevated levels of NDMA that to test and recall more of them could lead to shortages and patients being unable to get their necessary prescription medication.

The Zantac recall has already had an impact on heartburn and acid reflux sufferers who were advised by the FDA to switch to drugs like Prilosec that have not tested positive for high levels of NDMA. Prilosec omeprazole, (Pepcid), cimetidine (Tagamet), esomeprazole (Nexium), lansoprazole (Prevacid), or (Prilosec) are all suspected, however, of increasing one's chance of contracting Covid-19 as these drugs are protein pump inhibitors (PPI). PPIs work by permanently blocking specific enzymes from secreting acid into the stomach. A recent study reported by Time Magazine quoted the study's director Dr. Brennan Spiegel that he was not surprised that there is a connection between PPI drugs and cases of the Coronavirus because, "(PPIs) drugs reduce stomach acid, and acid is one way the body kills off potentially harmful bacteria and viruses." Zantac users left in the lurch without a safe drug to switch to are urged to consider making more healthy lifestyle decisions and giving up drinking caffeine or eating spicy foods.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.